Johnson & Johnson Focuses on Discussions, Data, Diversity, and Innovation to Help Advance Modern Practices and Patient Outcomes at AAO
Johnson & Johnson heads to AAO 2023, the Academy’s 127th annual meeting in San Francisco, California on November 3-6. In addition to showcasing the Johnson & Johnson Vision portfolio of innovations for the treatment of cataracts, refractive errors, and pediatric myopia, the company is hosting booth-talks and investigator-lead studies supporting the TECNIS PC-IOL Portfolio.
In a series of talks in Booth 1121 titled “A Modern Practice, Hear from Your Peers,” the J&J Vision team will host peer-led discussions Saturday and Sunday with leaders in ophthalmology. Panelists will share their experiences and answer questions about how to maximize the latest technology to grow a premium practice in support of patient outcomes.
- Maximize Your Results: How to Leverage the Versatility of Modern PC IOL Technology (Saturday, Nov. 4: 11:00 – 11:50AM & Sunday, Nov. 5: 1:00 – 1:50PM)
- Speakers: Blake Williamson, MD; Priya Mathews, MD; Elizabeth Yeu, MD; George Waring, MD
- Distance Plus, Without Compromise Get the Most from Your Monofocal IOL (Saturday, Nov. 4 1:00 – 1:50PM & Sunday, Nov. 5: 10:00 – 10:50AM)
- Speakers: Eric Donnenfeld, MD; Karolinne Maia Rocha, MD; Zaina Al-Mohtaseb, MD; Jai Parekh, MD
- ELITA: A Generational Leap in Refractive Technology (Saturday, Nov. 4: 2:00 – 2:50 PM)
- Speakers: Brian Schwam, MD; Hong Fu, Ph.D.
- Elevate Your Game: Delivering Patient Value to Grow Your Practice (Sunday, Nov. 5: 11:00 – 11:50 AM)
- Speakers: Daniel Chang, MD; Saralee Esau, COA, CPSS
- Leading The Way – MGD Diagnosis & Treatment in Surgical Patients (Sunday, Nov. 5: 2:00 – 2:50 PM)
- Speakers: Marguerite McDonald, MD; Marjan Farid, MD
Several poster presentations will share results from Investigator Lead Studies evaluating the performance and patient outcomes achieved with TECNIS Symfony Optiblue and TECNIS Synergy IOLs.
- Clinical Performance of a Diffractive EDOF IOL with a Violet Light Filter and High-Resolution Lathing; Poster PO030; Daniel H. Chang, MD, et al
- Reports that the technologies featured in the TECNIS Symfony OptiBlue IOL helped reduce halos and starbursts at 1 month, while maintaining patient satisfaction and visual performance at 1 and 6 months.
- Influence of Visual Field on VA and Contrast Sensitivity in Glaucomatous Eye with EDOF IOL; Poster PO034; Yuka Ota, MD, PhD, et al
- Determined that contrast sensitivity (CS) at higher special frequency was influenced by some perimetry indexes in eyes affected by primary open-angle glaucoma that were treated with TECNIS Symfony OptiBlue.
- Combining an EDOF and EDOF-Multifocal IOL for Presbyopia Correction: Clinical Outcomes; Poster PO051; George O. Waring IV, MD, et al
- Demonstrated that patients fitted with a combination of TECNIS Symfony OptiBlue and TECNIS Synergy IOLs achieved a wide range of vision.
Following the announcement of the initial findings of the Women in Ophthalmology survey from Johnson & Johnson Vision, a panel in the J&J Booth will discuss the inequities disproportionately faced by women ophthalmologists and ways the community can ignite action to ensure female ophthalmologists can thrive in their quest to improve sight for patients.
- Women Leaders In Ophthalmology: Breaking Barriers (Saturday, Nov. 5: 3:00 – 3:50 PM)
- Speakers: Lisa Nijm, MD; Sonia Yoo, MD; Zaina Al-Mohtaseb, MD.
AAO attendees can explore the broad range of ophthalmic innovations that Johnson & Johnson Vision offers to improve sight for cataract, refractive, and myopia patients:
- TECNIS Symfony OptiBlue – This all-purpose EDOF offers the best* contrast and low light performance in the category.
- TECNIS Synergy – This high-performance hybrid provides the best near**2 , contrast and low light performance1234 in the spectacle independence category***.
- TECNIS Eyhance – This monofocal IOL is a distance plus****, without compromise***** lens.
- CATALYS – This premium laser cataract system, with all-new cOS7, provides improved efficiency to enhance ease and speed throughout procedures with the push of a button .
- ELITA Femtosecond Laseri – Designed to deliver surgeon confidence and accuracy , practice efficiency , and improved visual outcomes and recovery for patients .
- TearScience Portfolio – Helps optimize surgical outcomes by proactively evaluating Meibomian glands’ function and treating Meibomian Gland Dysfunction prior to cataract and refractive procedures.
- ACUVUE Abiliti Overnight Therapeutic Lenses for Myopia Management.
* vs. AcrySof® ReSTOR® +2.5 D and AcrySof® IQ Vivity®
** vs. Acrysof IQ PanOptix®, TECNIS Symfony™, TECNIS® Multifocal. Based on comparison of DFU defocus curves and a head-to-head clinical study vs. PanOptix®
*** vs PanOptix® IOL
**** The TECNIS Eyhance™ IOLs are designed to slightly extend the depth of focus compared to the TECNIS™ 1-Piece IOL, Model ZCB00 as measured in bench testing.
***** Best contrast and low light performance day and night vs Acrysof® IQ (SN60WF), Clareon® (CNA0T0), Vivinex™ (XY1), enVista® (MX60E) and Acrysof® (SA60AT).
